logo
Select company
Select metric
5.27%EBIT Margin
VS
Market
48
Sector
74
Industry
85
History
100
$ 14.81Close
$ 5.3 - $ 18 52-Week Range
Ticker Information

Ticker

ATRA

Company Name

ATARA BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATARA BIOTHERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATRA - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ 9.95M5.27%$ 188.67M
3/31/2025$ -11.2M-5.61%$ 199.73M
12/31/2024$ -80.8M-62.66%$ 128.94M
9/30/2024$ -128.37M-127.81%$ 100.44M
6/30/2024$ -176.05M-282.18%$ 62.39M
3/31/2024$ -227.99M-656.95%$ 34.7M
12/31/2023$ -270.83M-3159.06%$ 8.57M
9/30/2023$ -287.1M-6321.05%$ 4.54M
6/30/2023$ -303.3M-4419.39%$ 6.86M
3/31/2023$ -215.47M-374.83%$ 57.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATARA BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, ATARA BIOTHERAPEUTICS INC's average EBIT % has been -1958.56%.
  • The median EBIT % for ATARA BIOTHERAPEUTICS INC during this period was -515.89%
  • ATARA BIOTHERAPEUTICS INC reached its highest EBIT % over the past 5 years at 5.27%.
  • The lowest EBIT % recorded by ATARA BIOTHERAPEUTICS INC in the same timeframe -8800.68%

ATARA BIOTHERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
IGMS : IGM BIOSCIENCES INC -36.8%STRO : SUTRO BIOPHARMA INC -174.93%MGNX : MACROGENICS INC -20.84%CHRS : COHERUS ONCOLOGY INC 136.5%IPSC : CENTURY THERAPEUTICS INC -18.85%KPTI : KARYOPHARM THERAPEUTICS INC -57.38%DOMH : DOMINARI HOLDINGS INC -36.01%MGX : METAGENOMI INC -267.38%FBIO : FORTRESS BIOTECH INC -0.34%ZYXI : ZYNEX INC -13.91%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ATARA BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ -307.05M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

ATRA - EBIT Margin, Last 5 years

-8800.68%

Minimum

Mar 31, 2021

5.27%

Maximum

Jun 30, 2025

-1958.56%

Average

-515.89%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%